Atlas Trials

Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia

Clinical trial NCT00876304 · COMPLETED

Trial details

NCT number
NCT00876304
Sponsor
Taisho Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2009-04-01
Primary completion
2009-09-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.